Retinal Dystrophy Rod clinical trials at University of California Health
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The purpose of this study is to characterize the natural history through temporal systemic evaluation of subjects identified with PRPF31 mutation-associated retinal dystrophy, also called retinitis pigmentosa type 11, or RP11. Assessments will be completed to measure and evaluate structural and functional visual changes including those impacting patient quality of life associated with this inherited retinal condition and observing how these changes evolve over time.
Our lead scientists for Retinal Dystrophy Rod research studies include Jacque Duncan, MD.